Brief: Titan Pharmaceuticals Provides Shareholder Update
15/12/2022 14:11
Dec 15 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS PROVIDES SHAREHOLDER UPDATE
* TITAN PHARMACEUTICALS INC - SIGNS NON-BINDING LETTER OF
INTENT
FOR TRANSFORMATIONAL TRANSACTION
* TITAN PHARMACEUTICALS INC - ENTERED A NON-BINDING LETTER
OF
INTENT TO COMPLETE A REVERSE MERGER WITH A LEADING DEVELOPER IN
ADVANCED AIR MOBILITY
Source text for Eikon: ID:nGNX6QYHyV
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.